The U.S. Food and Drug Administration approved a new non-opioid pain medication developed by the Massachusetts-based company ...

The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.

Vertex Pharmaceuticals (Nasdaq: VRTX) announced today a reimbursement agreement with NHS England for eligible sickle cell disease (SCD) patients to access the CRISPR/Cas9 gene-edited therapy, CASGEVY® ...

Vertex Pharmaceuticals Incorporated (Nasdaq ... Vertex was founded in 1989 and has its global headquarters in Boston, with international headquarters in London. Additionally, the company has ...

Vertex Pharmaceuticals Incorporated (Nasdaq ... Vertex was founded in 1989 and has its global headquarters in Boston, with international headquarters in London. Additionally, the company has research ...

The S&P 500 Index ($SPX) (SPY) Friday closed up +1.26%, the Dow Jones Industrials Index ($DOWI) (DIA) closed up +0.80%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed ...

Kim also led the company’s transition to a public entity and strategic collaborations with pharmaceutical companies such as Takeda, Vertex and Bristol Myers ... including at Enveda’s Asian ...

A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...

Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at ...

In a report released today, Greg Harrison from Scotiabank maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report), with a ...

Jan 30 (Reuters) - The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals' (VRTX.O), opens new tab drug to treat acute pain, the health regulator said on Thursday, offering a ...